<DOC>
	<DOCNO>NCT00159614</DOCNO>
	<brief_summary>The purpose study characterize safety tolerability KW-3902IV measure effect renal function .</brief_summary>
	<brief_title>Effect KW-3902IV Combination With IV Furosemide Renal Function Subjects With CHF Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Rolofylline</mesh_term>
	<criteria>Stable congestive heart failure Impaired renal function Taking oral loop diuretic Acutely decompensated ( unstable ) end stage heart failure Diuretics loop diuretic Pregnant nursing Inability follow instruction Participation another clinical trial within past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>renal insufficiency</keyword>
	<keyword>diuretic</keyword>
	<keyword>heart failure , congestive</keyword>
</DOC>